Medifast, Inc.
0K05.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$137.72M
Close$
$16.37
38.8% upside
Current Fair Value
38.8% upsideUndervalued by 38.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $137.72 Million |
|---|---|
| Enterprise Value | $98.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.65 |
| Outstanding Shares | 11,135,000 |
Return
| Return on Equity | -13.04% |
|---|---|
| Return on Assets | -9.83% |
| Return on Invested Capital | -7.30% |
Valuation & Multiples
| P/E Ratio | -4.98 |
|---|---|
| PEG | 2.21 |
| Price to Sales | 0.42 |
| Price to Book Ratio | 0.69 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | -6.18 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.65
Average shareholder expectationRevenue Estimate
$72.70 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$71.30 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medifast Inc
550 employees
CEO: Daniel Chard Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...